Virological Suppression in HIV Positive Patients Involved in a Novel Standardized Adherence Protocol

Phase 3

Completed

• Conditions: Hiv

• Registration Number: NCT03517358
• Lead Sponsor: University of California, Davis

Brief Summary

This study will look at virologically suppression of patients with HIV who receive pharmacist or case management care.

Detailed Description

Not available

Study Timeline

• Study Start: 2018-01-01
• Study First Submitted: 2018-04-10
• Primary Completion: 2018-05-01
• Study Completion: 2018-05-01
• Study First Submitted QC: 2018-05-03
• Study First Posted: 2018-05-07
• Status Verified: 2020-07
• Last Update Submitted: 2020-07-30
• Last Update Posted: 2020-07-31

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 10

Inclusion Criteria

• Patients with a baseline viral load > 200 copies/ml
• Patients who agree to program enrollment
• Patients ≥ 18 years of age

Exclusion Criteria

• Pregnant women
• Adults unable to consent
• Prisoners

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Percentage of virological suppression	6 months

Trial Locations

Locations (1)

One Community Health; 🇺🇸 Sacramento, California, United States